Literature DB >> 8607090

Hydrocephalus and macrocrania: surgical or non-surgical treatment of postshunting subdural hematoma?

A Puca1, E Fernandez, C Colosimo, L Lauretti, R Pallini, G Tamburrini.   

Abstract

BACKGROUND: Subdural hematoma is a well-known complication of hydrocephalus shunting procedures. Since the advent of modern neuroimaging techniques, a more realistic incidence of subdural hematomas in shunted patients has been recognized. The description of several asymptomatic cases raises the problem of choosing the most appropriate therapeutic policy for such a condition.
METHODS: We report two cases with long standing hydrocephalus and macrocrania in which bilateral huge acute and subacute postshunting subdural hematoma developed and remained asymptomatic.
RESULTS: The first patient was treated initially by surgery. Subsequently, despite the persistence of the subdural collections, a nonsurgical policy was chosen. The second patient was deliberately nonsurgically treated.
CONCLUSIONS: On the basis of our experience, we conclude that a nonsurgical policy should be followed in patients with long standing hydrocephalus and macrocrania, if they develop postshunting large hemorrhagic subdural collections and remain asymptomatic.

Entities:  

Mesh:

Year:  1996        PMID: 8607090     DOI: 10.1016/0090-3019(95)00450-5

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  2 in total

1.  Preoperative risk and postoperative outcome from subdural fluid collections in African infants with postinfectious hydrocephalus.

Authors:  Jessica R Lane; Paddy Ssentongo; Mallory R Peterson; Joshua R Harper; Edith Mbabazi-Kabachelor; John Mugamba; Peter Ssenyonga; Justin Onen; Ruth Donnelly; Jody Levenbach; Venkateswararao Cherukuri; Vishal Monga; Abhaya V Kulkarni; Benjamin C Warf; Steven J Schiff
Journal:  J Neurosurg Pediatr       Date:  2021-10-01       Impact factor: 2.713

2.  Armored brain in a young girl with a syndromal hydrocephalus.

Authors:  Ilaria Viozzi; Kirsten van Baarsen; André Grotenhuis
Journal:  Acta Neurochir (Wien)       Date:  2016-10-25       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.